NeuroMetrix, Inc. to Present at the Lazard Capital Markets Third Annual Life Sciences Conference on Wednesday, November 29, 2006

NeuroMetrix, Inc. (NASDAQ: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced today that it is scheduled to present at the Lazard Capital Markets Third Annual Life Sciences Conference at The New York Palace Hotel in New York City at 11:00 am (EST) on Wednesday, November 29, 2006. The audio presentation will be simultaneously available via webcast on the "Investors” home page at http://www.neurometrix.com. Gary Gregory, NeuroMetrix Chief Operating Officer, will be presenting at the conference. Mr. Gregory will provide an overview of NeuroMetrix and will provide an update on operational and strategic matters relating to the business. About NeuroMetrix NeuroMetrix is a medical device company that is establishing a new standard of care through the design, development and sale of proprietary products used to help physicians diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders. The NC-stat System, the Company's neuropathy diagnostic system, has been on the market since May 1999 and is presently used in over 4,500 physician's offices and clinics in the United States. The Company holds issued utility patents covering a number of important aspects of the NC-stat System.